Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Disposal Update

4th Mar 2016 07:00

RNS Number : 0296R
UDG Healthcare Public Limited Co.
04 March 2016
 

4 March 2016

 UDG Healthcare PLC

Disposal Update

 

UDG Healthcare plc ("the Company") can confirm that further to the announcements on 18 September 2015 and 13 October 2015, regarding the proposed disposal of its United Drug Supply Chain and MASTA businesses to McKesson Corporation, the European Commission has confirmed competition clearance for the businesses based in the Republic of Ireland. The European Commission has referred the UK aspects of the proposed transaction to the United Kingdom's Competition and Markets Authority for review. Notwithstanding the referral to the Competition and Markets Authority, the clearance from the European Commission enables the transaction to complete in full and this is now expected to occur on 1 April 2016.

 

For further information, please contact:

 

Investors and Analysts:

Alan Ralph

CFO

UDG Healthcare plc

Tel: +353-1-463-2300

 

 

Keith Byrne

Head of Investor Relations and Strategy

UDG Healthcare plc

Tel: + 353-1-463-7722

 

Media:

Business / Financial media:

Lisa Kavanagh / Jack Hickey

Powerscourt

Tel: +44-207-250-1446

 

 

 

About UDG Healthcare plc:

 

Listed on the London Stock Exchange, UDG Healthcare plc is a leading international provider of services to the healthcare industry, with operations in 20 countries including the US, UK, Ireland and Germany.

 

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services.

 

Ashfield Commercial & Medical Services is a global leader in the provision of sales, marketing and healthcare communications services to pharmaceutical manufacturers with operations in major developed markets. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to healthcare companies in 19 countries.

 

Sharp Packaging Services is a leading international provider of pharmaceutical contract packaging and clinical trials materials services with facilities in the US, UK, the Netherlands and Belgium.

 

Supply Chain Services consists of Aquilant Specialist Healthcare Services, a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in Ireland and the UK.

 

For more information please go to: www.udghealthcare.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISSSUEFDFMSESD

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00